![Peter Radovich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Radovich
Presidente presso
MIRUM PHARMACEUTICALS, INC.
Patrimonio netto: 6 M $ in data 31/07/2026
Profilo
Peter Radovich is President & Chief Operating Officer at Mirum Pharmaceuticals, Inc. since 2024, with employment at the firm starting in 2020.
Former positions include Independent Director at Rain Oncology, Inc. from 2018 to 2024; Senior Vice President-Operations at Global Blood Therapeutics, Inc. from 2016 to 2020; Vice President-Global Product Kyprolis at Onyx Pharmaceuticals, Inc. from 2013 to 2014; Senior Director & VP-Program Leadership at Onyx Pharmaceuticals, Inc. from 2004 to 2006; and Principal at Chiron Corp.
from 2004 to 2006.
Education includes an MBA from the University of Washington and undergraduate studies at Texas Christian University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 57.260 ( 0,09% ) | 6 M $ | 31/07/2026 |
Posizioni attive di Peter Radovich
| Società | Posizione | Inizio |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Presidente | 16/01/2024 |
Precedenti posizioni note di Peter Radovich
| Società | Posizione | Fine |
|---|---|---|
| RAIN ONCOLOGY INC. | Direttore/Membro del Consiglio | 25/01/2024 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Direttore operativo | 01/04/2020 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01/01/2014 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Direttore/Membro del Consiglio | 01/09/2006 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01/01/2006 |
Formazione di Peter Radovich
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
 Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
